Skip to Main Content

Author Details

Janet L Stanford
Fred Hutchinson Cancer Research Center
1980
369
85
PMIDPaper TitleJournal TitlePublished Year
35995710Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.Eur Urol Oncol2023
35995710Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.Eur Urol Oncol2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37555839Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study.Cancer Epidemiol Biomarkers Prev2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
36599183Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.Eur J Cancer2023
37555839Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study.Cancer Epidemiol Biomarkers Prev2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
36599183Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.Eur J Cancer2023
34993496Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG Adv2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
35400115A multiple-testing procedure for high-dimensional mediation hypotheses.J Am Stat Assoc2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
34993496Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.HGG Adv2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
35400115A multiple-testing procedure for high-dimensional mediation hypotheses.J Am Stat Assoc2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
32800727Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.Eur Urol2021
33956343A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.Prostate2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
34275018Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium.Eur J Epidemiol2021
33623038Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.Nat Commun2021
33713608Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.Am J Hum Genet2021
33821477A rare variant in EZH2 is associated with prostate cancer risk.Int J Cancer2021
32800727Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.Eur Urol2021
33420416Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.Prostate Cancer Prostatic Dis2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33436325Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.Eur Urol Oncol2021
34736042Massively parallel sequencing in hereditary prostate cancer families reveals a rare risk variant in the DNA repair gene, RAD51C.Eur J Cancer2021
33713608Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.Am J Hum Genet2021
33623038Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.Nat Commun2021
33821477A rare variant in EZH2 is associated with prostate cancer risk.Int J Cancer2021
34736042Massively parallel sequencing in hereditary prostate cancer families reveals a rare risk variant in the DNA repair gene, RAD51C.Eur J Cancer2021
34275018Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium.Eur J Epidemiol2021
33956343A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.Prostate2021
33436325Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.Eur Urol Oncol2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33420416Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.Prostate Cancer Prostatic Dis2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
32251068Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study.Epidemiology2020
32251068Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study.Epidemiology2020
32071439Copy number alterations are associated with metastatic-lethal progression in prostate cancer.Prostate Cancer Prostatic Dis2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
  • 1 - 50 of 738

Recommended Authors

Mieke Van Hemelrijck
School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year 2007
Number of shared co-authors 6
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 19
Mine S Cicek
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 88
Channing J Paller
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 13
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 34
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 30
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 39
Clara Bodelon
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 83
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 43
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 19
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 26
Reina Haque
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 8
Dina N Paltoo
National Institutes of Health
Career Start Year 1998
Number of shared co-authors 31
James V Lacey
Beckman Research Institute of City of Hope
Career Start Year 1997
Number of shared co-authors 66
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 28
Stephen J Freedland
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 46
Ming-Hui Chen
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 6
Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 28
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 37
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 19
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 52
N??ria Malats
Spanish National Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 69
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 8
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 38
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 17
Fran??ois Meyer
Laval University
Career Start Year 1986
Number of shared co-authors 4
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 31
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 38
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 51
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 12

Collaborators

Elaine A Ostrander
National Cancer Institute
Co-authored papers 140
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 63
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 62
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 61
Christopher A Haiman
University of Southern California
Co-authored papers 60
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 59
Douglas F Easton
University of Cambridge
Co-authored papers 59
Fredrik Wiklund
Co-authored papers 58
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 57
William J Blot
Vanderbilt University Medical Center
Co-authored papers 55
Graham G Giles
Co-authored papers 54
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 53
Sonja I Berndt
Co-authored papers 48
Daniel J Schaid
Mayo Clinic
Co-authored papers 48
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 44
Sue A Ingles
Co-authored papers 44
Shannon K McDonnell
Mayo Clinic
Co-authored papers 43
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 43
Jianfeng Xu
Co-authored papers 42
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 41
Ruth C Travis
Co-authored papers 40
Esther M John
Co-authored papers 39
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 38
Børge G Nordestgaard
Co-authored papers 38
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 35
Kay-Tee Khaw
Co-authored papers 33
Daniel W Lin
Co-authored papers 32
Marilie D Gammon
Co-authored papers 31
John D Carpten
Co-authored papers 31
Brian E Henderson
University of Southern California
Co-authored papers 30
Release 1.2